Multicellular 3D Models of Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 15 December 2025 | Viewed by 761
Special Issue Editors
Interests: 3D in vitro cancer models; tumouroids; targeted treatments; theranostics; nanotechnology; precision oncology; patient-derived 3D models
Special Issues, Collections and Topics in MDPI journals
Interests: cancer models; 3D models; fibrosis; matrix stiffness; pancreatic cancer; liver cancer; ovarian cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The focus of this Special Issue is to highlight novel research findings in multicellular 3D in vitro models of cancer. Multicellularity mimics the in vivo scenario and helps in developing relevant biomimetic models to investigate disease progression and test drugs. As highlighted by the FDA, 3D in vitro models hold great promise for low-cost animal-free testing.
We welcome research articles focused on developing complex models of the cancer microenvironment with a strong focus on multicellularity. We particularly encourage submissions on primary tissue work and the development of biomaterial-based animal-free models.
Prof. Dr. Marilena Loizidou
Prof. Dr. Eirini Velliou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- 3D in vitro cancer models
- multicellular cancer models
- cancer microenvironment
- tumour–stroma interactions
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
